Factors associated with continuous naloxone infusion use following opioid overdose in the emergency department
INTRODUCTION: Contemporary data on naloxone infusion use are limited. We seek to identify factors associated with infusion use and characterize clinical outcomes. METHODS: We performed a retrospective cohort study of emergency department encounters between July 2019 and December 2024 involving patients with nonfatal opioid overdose who received naloxone. Sociodemographic characteristics, comorbidities, toxicologic findings, naloxone administration patterns, and clinical outcomes were compared between encounters with and without infusion. Multivariable logistic regression was used to identify factors independently associated with naloxone infusion use and selected clinical outcomes. RESULTS: A total of 1,165 encounters met inclusion criteria, including 227 (19.5%) involving naloxone infusion. In adjusted analyses, fentanyl positivity (aOR 2.96, 95% CI 1.92-4.57) and combined opioid-stimulant positivity (aOR 3.00, 95% CI 1.99-4.53) were independently associated with naloxone infusion use, whereas opiate positivity was associated with lower odds of infusion (aOR 0.50, 95% CI 0.34-0.73). Infusion use increased over the study period, and prolonged infusions occasionally resulted in substantial intravenous fluid exposure. DISCUSSION: Associations of fentanyl and stimulant positivity with naloxone infusion may reflect changing overdose patterns amid increasing fentanyl and stimulant co-exposure. Substantial fluid administration during prolonged infusions highlights a potentially underrecognized consequence of dilute preparations. Given the observational design, associations with infusion use are hypothesis-generating and should not be interpreted as causal. CONCLUSIONS: Evolving patterns of fentanyl and stimulant co-exposure may influence naloxone infusion use following opioid overdose.
Authors
- Griffin Russell
- Stacy Marshall (ORCID: https://orcid.org/0009-0003-0872-2833)
- Gregory G. Davis (ORCID: https://orcid.org/0000-0001-8932-296X)
- William Bradford
- Lauren A. Walter
- Julie Brown
Institutions
- University of Alabama (US)
- University of Alabama at Birmingham (US)
- Jefferson County Department of Health (US)
Publication Details
- Journal
- Clinical Toxicology
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1080/15563650.2026.2762170
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Purdue Pharma